1. Dysregulated micro-RNAs and long noncoding RNAs in cardiac development and pediatric heart failure
    Lee Toni et al, 2020, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
  2. MicroRNAs in extracellular vesicles: Sorting mechanisms, diagnostic value, isolation, and detection technology
    Dongjie Xu et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef
  3. Inhibition of Senescence‐Associated Genes Rb1 and Meis2 in Adult Cardiomyocytes Results in Cell Cycle Reentry and Cardiac Repair Post–Myocardial Infarction
    Perwez Alam et al, 2019, Journal of the American Heart Association CrossRef
  4. Adverse Intrauterine Environment and Cardiac miRNA Expression
    Mitchell Lock et al, 2017, International Journal of Molecular Sciences CrossRef
  5. The therapeutic and diagnostic role of exosomes in cardiovascular diseases
    Parvin Zamani et al, 2019, Trends in Cardiovascular Medicine CrossRef
  6. Potential Impact of MicroRNA Gene Polymorphisms in the Pathogenesis of Diabetes and Atherosclerotic Cardiovascular Disease
    Imadeldin Elfaki et al, 2019, Journal of Personalized Medicine CrossRef
  7. Cell therapy for the treatment of heart disease: Renovation work on the broken heart is still in progress
    Paolo Madeddu, 2021, Free Radical Biology and Medicine CrossRef
  8. Association between single-nucleotide polymorphisms of NKX2.5 and congenital heart disease in Chinese population: A meta-analysis
    Huan Chen et al, 2022, Open Life Sciences CrossRef
  9. Exosomal non-coding RNAs (Exo-ncRNAs) in cardiovascular health
    Carolina Jaquenod De Giusti et al, 2019, Journal of Molecular and Cellular Cardiology CrossRef
  10. Differential expression of novel MicroRNAs from developing fetal heart of Gallus gallus domesticus implies a role in cardiac development
    Sharad Saxena et al, 2019, Molecular and Cellular Biochemistry CrossRef
  11. LncRNA nuclear-enriched abundant transcript 1 regulates hypoxia-evoked apoptosis and autophagy via mediation of microRNA-181b
    Ying Lv et al, 2020, Molecular and Cellular Biochemistry CrossRef
  12. Congenital heart diseases: genetics, non-inherited risk factors, and signaling pathways
    Emmanuel Suluba et al, 2020, Egyptian Journal of Medical Human Genetics CrossRef
  13. Effect of EPOC on Serum MicroRNA Expression in Patients with Hypertension
    Hao Li et al, 2022, Journal of Healthcare Engineering CrossRef
  14. Regulatory Mechanisms That Guide the Fetal to Postnatal Transition of Cardiomyocytes
    Patrick G. Burgon et al, 2023, Cells CrossRef
  15. MicroRNAs in chronic pediatric diseases (Review)
    Mingyao Zhang et al, 2024, Experimental and Therapeutic Medicine CrossRef
  16. MicroRNAs: roles in cardiovascular development and disease
    Samira Kalayinia et al, 2021, Cardiovascular Pathology CrossRef
  17. microRNAs and cardiac stem cells in heart development and disease
    Bo Li et al, 2019, Drug Discovery Today CrossRef
  18. MicroRNAs as Biomarkers and Therapeutic Targets in Heart Failure
    István Adorján Szabó et al, 2019, Acta Medica Marisiensis CrossRef
  19. Broadly active zinc finger protein-guided transcriptional activation of HIV-1
    Tristan A. Scott et al, 2021, Molecular Therapy - Methods & Clinical Development CrossRef
  20. MicroRNAs as novel biomarkers for the diagnosis and treatment of pediatric diseases
    Hwal Rim Jeong et al, 2024, Clinical and Experimental Pediatrics CrossRef
  21. A MicroRNA Perspective on Cardiovascular Development and Diseases: An Update
    Jose Francisco Islas et al, 2018, International Journal of Molecular Sciences CrossRef
  22. Resveratrol Modulates miR-34a in Cardiotoxicity Induced by Isoproterenol
    Sylvia A. Boshra, 2020, Journal of Medicinal Food CrossRef
  23. MiR-210 facilitates ECM degradation by suppressing autophagy via silencing of ATG7 in human degenerated NP cells
    Cheng Wang et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  24. MicroRNAs and Congenital Heart Disease: Where Are We Now?
    Silvia Pulignani et al, 2019, Revista Española de Cardiología (English Edition) CrossRef
  25. The Cardiovascular Disease (CVD) Risk Continuum from Prenatal Life to Adulthood: A Literature Review
    Maria Felicia Faienza et al, 2022, International Journal of Environmental Research and Public Health CrossRef
  26. Genetic detection of congenital heart disease
    Sumathi I. Rachamadugu et al, 2022, Gynecology and Obstetrics Clinical Medicine CrossRef
  27. Comparison of serum microRNA in healthy horses and horses with moderate to severe mitral valve regurgitation using a commercially available canine cardiac panel
    Amber Calewaert et al, 2024, Equine Veterinary Journal CrossRef
  28. El papel de los microARN en las cardiopatías congénitas: qué sabemos
    Silvia Pulignani et al, 2019, Revista Española de Cardiología CrossRef
  29. Cocaine Exposure Increases Blood Pressure and Aortic Stiffness via the miR-30c-5p–Malic Enzyme 1–Reactive Oxygen Species Pathway
    Wei Zhu et al, 2018, Hypertension CrossRef
  30. miRReg: A Framework for Studying miRNA Regulation in Tetralogy of Fallot
    Guangbin Wang et al, 2020, IEEE Access CrossRef
  31. FGD5-AS1 Is a Hub lncRNA ceRNA in Hearts With Tetralogy of Fallot Which Regulates Congenital Heart Disease Genes Transcriptionally and Epigenetically
    Xingyu Zhang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  32. MicroRNA-208a Correlates Apoptosis and Oxidative Stress Induced by H2O2 through Protein Tyrosine Kinase/Phosphatase Balance in Cardiomyocytes
    Aijun Liu et al, 2018, International Heart Journal CrossRef
  33. MicroRNA and Its Role in Cardiovascular Disease
    Suvash Pokhrel et al, 2017, World Journal of Cardiovascular Diseases CrossRef
  34. MicroRNA‐138 Inhibits Osteogenic Differentiation and Mineralization of Human Dedifferentiated Chondrocytes by Regulating RhoC and the Actin Cytoskeleton
    Hongjun Zheng et al, 2019, JBMR Plus CrossRef
  35. microRNA-212-induced protection of the heart against myocardial infarction occurs via the interplay between AQP9 and PI3K/Akt signaling pathway
    Ning Ren et al, 2018, Experimental Cell Research CrossRef
  36. The impacts of intrauterine Bisphenol A exposure on pregnancy and expression of miRNAs related to heart development and diseases in animal model
    Zatilfarihiah Rasdi et al, 2020, Scientific Reports CrossRef
  37. MicroRNA-Mediated Direct Reprogramming of Human Adult Fibroblasts Toward Cardiac Phenotype
    C. Paoletti et al, 2020, Frontiers in Bioengineering and Biotechnology CrossRef
  38. Exploring ribosome composition and newly synthesized proteins through proteomics and potential biomedical applications
    Miroslava Stastna et al, 2017, Expert Review of Proteomics CrossRef
  39. MicroRNA‑708‑5p affects proliferation and invasion of osteosarcoma cells by targeting URGCP
    Cong Sui et al, 2019, Experimental and Therapeutic Medicine CrossRef
  40. MicroRNAs in Cardiac Hypertrophy
    Nadine Wehbe et al, 2019, International Journal of Molecular Sciences CrossRef
  41. Circulating MicroRNAs: a Potential Biomarker for Cardiac Damage, Inflammatory Response, and Left Ventricular Function Recovery in Pediatric Viral Myocarditis
    Lior Goldberg et al, 2018, Journal of Cardiovascular Translational Research CrossRef
  42. MicroRNA-499a-5p Promotes Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells to Cardiomyocytes
    Vajiheh Neshati et al, 2018, Applied Biochemistry and Biotechnology CrossRef
  43. Potential impact of GCK, MIR-196A-2 and MIR-423 gene abnormalities on the development and progression of type 2 diabetes mellitus in Asir and Tabuk regions of Saudi Arabia
    Mohammad Mir et al, 2022, Molecular Medicine Reports CrossRef
  44. Upregulating MicroRNA-203 Alleviates Myocardial Remodeling and Cell Apoptosis Through Downregulating Protein Tyrosine Phosphatase 1B in Rats With Myocardial Infarction
    Jing Zhang et al, 2019, Journal of Cardiovascular Pharmacology CrossRef
  45. Linc8986 and linc0597 in plasma are novel biomarkers for systemic lupus erythematosus
    Chunli Rong et al, 2021, Experimental and Therapeutic Medicine CrossRef